In short. The quiet weeks after a biostimulator session are the treatment working, not failing. How to get through them without concluding too early or asking for more.
Key points
- Fix the judgement point in advance and do not move it.
- If the plan says the result is judged at three months against baseline photographs, then the weeks before that date are not evidence of anything, and neither is any opinion formed in them.
- Moving it earlier converts a slow process into an apparent failure.
The most common reason a biostimulator course fails is not the substance, the injector or the tissue. It is that the patient stopped during the quiet weeks. Somewhere between week three and week six almost nothing looks different, and that is exactly what a course in progress looks like. Understanding why it exists is the difference between finishing a course and abandoning one about to work.
What is actually happening in the quiet weeks
What you saw on treatment day was carrier gel, and much of it has already gone. What you are waiting for is your own tissue’s response, laid down slowly and invisibly over weeks. There is no stage at which you can feel it happening, and no mirror check that will show it early. The absence of visible change at six weeks carries no information at all about whether the treatment is working.
The comparison that is worth making
A mirror is a poor instrument for a gradual change, because you see your face every day and memory adjusts. A standardised photograph — same light, same angle, same distance — at the same three-month point is the only fair comparison, and it is why clinics take baseline photographs before the first session. That photograph decides whether the course continues.
Judge at the review, not in the interim
Fix the judgement point in advance and do not move it. If the plan says the result is judged at three months against baseline photographs, then the weeks before that date are not evidence of anything, and neither is any opinion formed in them. Moving it earlier converts a slow process into an apparent failure.
What to do with the waiting
Fill it with things that do not compete with the treatment. Photoprotection matters because sun exposure ages the tissue the course is trying to support. Smoking works against it. Sleep and general health are not decoration. What does not help is mirror-checking, and what actively works against you is asking for another session to settle the anxiety, because treating tissue that is still responding to the previous session is how nodules and unevenness appear.
Ways patients derail a course
- Concluding at week six that it has not worked and stopping, which is the point at which most abandoned courses are abandoned.
- Asking for an extra session to speed things up, which adds risk without adding effect.
- Judging the result against a photograph taken in different light, at a different angle, or on a different day of the month.
The honest framing is that a biostimulator asks you to trust a process you cannot watch. That is an unusual thing to ask of a patient, and it is the reason this site states the quiet period plainly rather than leaving it to be discovered. If waiting two months without visible feedback is not something you want to do, the more suitable answer is probably a filler, which shows its result on the day and can be undone if you dislike it.
Frequently asked questions
Is it normal for nothing to look different at six weeks?
Yes, and it is expected. The early fullness was carrier gel and has already settled. Collagen is being deposited during these weeks but the change is too gradual to see in a mirror, which is why the fair judgement point is a standardised photograph at about three months.
Could I ask for an extra session during the quiet period?
You can ask, and the answer should usually be no. Adding a session to tissue that is still responding to the last one increases the risk of nodules and unevenness without speeding anything up. A clinician who agrees to it readily is responding to your anxiety rather than to your tissue.
How do I tell the difference between a slow result and a failed one?
You cannot tell by looking, and neither can anyone else, until the comparison is fair. A failed course is one that shows no change in standardised photographs after a full course at proper intervals. Anything judged earlier than that is a guess about a process still running.
Risks & Limitations
- Nodules and granulomas — firm lumps or an inflammatory reaction that can appear weeks or months after treatment and may need assessment and treatment rather than simply resolving.
- Irreversibility: a biostimulator cannot be dissolved. An uneven or unwanted result has to be managed over time, not switched off.
- Infection or inflammation at the injection site.
- Asymmetry or over-correction. Over-treatment in an area that cannot be dissolved is harder to correct than under-treatment.
- Lumpiness or irregularity in the first weeks while the material settles, which usually resolves but occasionally does not.
- Bruising, swelling, tenderness and occasional headache after treatment.
- A biostimulator does not lift descended tissue and does not remove fat. The effect is gradual over months, it is not permanent, and maintenance treatment is required.
When to Seek Care
- A firm, growing or painful lump at or near an injection site, appearing weeks or months after treatment — this needs assessment even when it is not painful.
- Redness, warmth, swelling or pus at an injection site, or fever.
- Skin breakdown, blistering, or a dusky or mottled patch over a treated area — seek care immediately.
- Increasing pain, or pain out of proportion to the injection.
- Difficulty breathing, facial swelling or a widespread rash — possible severe reaction; seek emergency care immediately.
References & Further Reading
- American Academy of Dermatology (AAD) — injectable and skin safety information
- American Society of Plastic Surgeons (ASPS) — injectable treatment guidance
- U.S. Food and Drug Administration (FDA) — approved injectable products and safety communications
- National Medical Products Administration (NMPA, China) — approved product status
- Chongqing West District Hospital — Plastic Surgery & Aesthetics Medical Center
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.